| Zacks Company Profile for DermTech, Inc. (DMTKQ : OTC) |
|
|
| |
| • Company Description |
| DermTech Inc. markets and develops products which facilitate early detection of skin cancers, assess inflammatory diseases and customize drug treatments. DermTech Inc., formerly known as Constellation Alpha Capital Corp., is based in La Jolla, United States.
Number of Employees: 208 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $ |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 10,378 shares |
| Shares Outstanding: 35.25 (millions) |
| Market Capitalization: $ (millions) |
| Beta: 2.59 |
| 52 Week High: $0.11 |
| 52 Week Low: $0.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
% |
% |
| 12 Week |
% |
% |
| Year To Date |
% |
% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Bret Christensen - Chief Executive Officer and Director
Kevin Sun - Chief Financial Officer and Treasurer
Cynthia Collins - Director
Matthew Posard - Director
Herm Rosenman - Director
|
|
Peer Information
DermTech, Inc. (CHCR)
DermTech, Inc. (ESRX)
DermTech, Inc. (MYDP)
DermTech, Inc. (COR)
DermTech, Inc. (GBCS)
DermTech, Inc. (LAXAF)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 24984K105
SIC: 8071
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding: 35.25
Most Recent Split Date: 8.00 (0.50:1)
Beta: 2.59
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: % |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
